Evidence map›Paper›PMID 33559128›Full record

ReviewImmunological reviews2021

Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19.

Alice R Burton, Mala K Maini

Open access · hybridAbstract readReview
In one paragraph

Review in Immunological reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Occult hepatitis B virus infection.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  2. Article
  3. SARS-CoV-2 Chronic Intervillositis: Variations of Maternal Antiviral Response.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  4. Article
  5. Modulating effects ofFrontiers in microbiology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alice R BurtonDivision of Infection and Immunity, UCL, London, UK.ORCID 0000-0003-1049-1176
Mala K MainiDivision of Infection and Immunity, UCL, London, UK.ORCID 0000-0001-6384-1462
Centre for Immunity, Infection and Evolution · GB

Funding

Wellcome Trust 101849/Z/13/A
6 · The paper itself

Abstract

Humoral immunity is a critical component of the coordinated response required to resolve viral infections and mediate protection following pathogen clearance or vaccination. A better understanding of factors shaping the memory B cell response will allow tailored development of efficient preventative vaccines against emerging acute viral infections, therapeutic vaccines, and immunotherapies for chronic viral infections. Here, we use recent data obtained by profiling antigen-specific B cell responses in hepatitis B as a framework to explore lessons that can be learnt from different viral infections about the diverse influences on humoral immunity. Hepatitis B provides a paradigm where successful B cell responses in resolved or vaccinated individuals can be contrasted to the failed response in chronic infection, while also exemplifying the degree to which B cell responses within infected individuals can differ to two antigens from the same virus. Drawing on studies in other human and murine infections, including emerging data from COVID-19, we consider the influence of antigen quantity and structure on the quality of the B cell response, the role of differential CD4 help, the importance of germinal center vs extrafollicular responses and the emerging concept that responses residing in non-lymphoid organs can participate in B cell memory.

Indexed as

Antibodies, ViralAntibody FormationAntigens, ViralB-LymphocytesCOVID-19COVID-19 VaccinesHepatitis BHepatitis B virusHumansImmunity, HumoralImmunodominant EpitopesImmunologic MemorySARS-CoV-2T-Lymphocytes, Helper-InducerAntibodies, ViralAntigens, ViralCOVID-19 VaccinesImmunodominant EpitopesB cellshumoral immunitymemory B cell differentiationviral infection

Identifiers

PMID33559128
PMCPMC8014162
OpenAlexW3128634655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.